Viewing Study NCT00361959


Ignite Creation Date: 2025-12-24 @ 2:52 PM
Ignite Modification Date: 2025-12-25 @ 6:06 PM
Study NCT ID: NCT00361959
Status: COMPLETED
Last Update Posted: 2017-01-20
First Post: 2006-08-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: SERETIDE 50/500mcg Versus Tiotropium Bromide On Exacerbation Rates In Severe Chronic Obstructive Pulmonary Disease
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pulmonary Disease, Chronic Obstructive View
Keywords:

Keywords

Keyword Brief Keyword Text View
None fluticasone propionate/salmeterol combination View
None tiotropium View
None SERETIDE View
None COPD exacerbation View